Hot Topic Discussion: Peter Marks, MD, PhD, Speaks to AABB Community on FDA's..

When:  Feb 2, 2023 from 02:00 PM to 03:00 PM (ET)
Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research (CBER), will discuss the FDA’s Jan. 27 draft guidance, "Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products” and its implications for the blood community.

Learn More
Event Image

Contact

AABB
301.215.6482
eLearning@aabb.org

Related Content